Palliative Surgical Management of Hilar Cholangiocarcinoma

By -

 


Executive Summary

Hilar cholangiocarcinomas, or Klatskin tumors, occur at the biliary confluence and represent 40–60% of all cholangiocarcinomas. Because only 20–30% of cases are suitable for curative resection, the majority of patients require palliative intervention to manage biliary obstruction and its complications, such as jaundice, cholangitis, and liver failure.

The primary palliative objective is the restoration of biliary drainage. While endoscopic and percutaneous methods are available, surgical biliary-enteric bypass offers superior long-term patency and lower rates of recurrent jaundice, despite higher initial morbidity and mortality. Among surgical options, the Segment III bypass (Round Ligament approach) is the most favored technique due to its predictable anatomy and its location safely distant from the primary tumor at the hilum. Percutaneous transhepatic biliary drainage (PTBD) remains the preferred method when unresectability is established prior to surgery.

Clinical Objectives and Preoperative Evaluation

The management of suspected hilar cholangiocarcinoma is governed by four primary preoperative objectives:

  1. Vascular and Biliary Assessment: Determining the extent of involvement in the portal vein, hepatic artery, and biliary tract.

  2. Hepatic Assessment: Identifying lobar atrophy or other concomitant liver pathologies.

  3. Metastatic Screening: Evaluating nodal disease or distant metastases.

  4. Fitness Evaluation: Assessing the patient’s overall physiological capacity for surgery.

For the minority of patients (20–30%) where curative surgery is possible, the goals are complete tumor excision with negative margins and restoration of bilioenteric continuity. For the remaining majority, treatment shifts toward improving quality of life through the relief of biliary obstruction.

Comparative Palliative Modalities

Several modalities exist to drain the biliary system when curative resection is not an option.

Modality

Description

Advantages

Disadvantages

Endoscopic

Plastic or metallic stents.

Minimally invasive.

High failure rate for hilar malignancies.

Percutaneous (PTBD)

Stent insertion through the skin.

More predictable placement than endoscopic; preferred if unresectability is known pre-surgery.

Ongoing management of external/internal catheters.

Surgical Bypass

Intrahepatic biliary-enteric anastomosis.

Higher long-term patency; lower incidence of recurrent jaundice.

Greater early morbidity and mortality; requires a major operative procedure.

Surgical Biliary Bypass Techniques

The choice of surgical technique is largely dictated by the tumor's location. Internal drainage to either the left or right side of the biliary system is generally sufficient to resolve jaundice.

1. Left Hepatic Duct Approaches

The left hepatic duct is frequently targeted because of its long extrahepatic course and consistent anatomy.

  • Segment III Bypass (Round Ligament Approach):

    • Mechanism: Accesses the segment III duct via the umbilical fissure by dividing the ligamentum teres.

    • Rationale: Technically easier and preferred because the anastomosis is performed at a distance from the hilar tumor.

    • Anatomical Basis: Research indicates that in 64.8% of cases, this bypass successfully drains segments II, III, and IV. In 35.2% of cases, the anatomy is unfavorable because the ducts for segments II or IV join too close to the confluence.

  • Extrafascial Approach:

    • Involves separating the hilar plate from the hepatic parenchyma to expose the left hepatic duct outside the Glissonian sheath. This is only applicable if the tumor has not infiltrated the hepatic plate.

  • Longmire Procedure:

    • Requires partial excision of the left lateral segment to expose segment II and III ducts. While historically common, it has been largely superseded by non-resectional techniques.

  • Cahow’s Procedure:

    • An anterior approach using dilated subcapsular ductules as guides. It is technically difficult due to the fragile nature and small lumen of peripheral ducts.

2. Right Hepatic Duct Approaches

Bypass to the right side is significantly more challenging due to a lack of precise anatomical landmarks.

  • Segment V/VI Approach: Requires a hepatotomy at the gallbladder fossa.

  • Anterior Sectoral Duct Approach: Involves resecting part of the liver to open the duct on the left aspect of the portal vein.

  • Limitations: These procedures are rarely performed because the peripheral ducts have thin walls and small lumens, making anastomosis technically difficult and hazardous.

Technical Outcomes and Evidence

Surgical intervention for palliation is characterized by a trade-off between immediate risk and long-term durability.

  • Efficacy: Segment III bypass provides jaundice relief in 73–100% of patients.

  • Complications: Perioperative mortality for Segment III bypass ranges from 0–11.5%, with morbidity rates between 13–45%.

  • Decision Factors: The choice between surgical and non-surgical palliation must consider the patient's age, physical condition, and predicted life expectancy.

Data Limitations

There is currently a lack of randomized controlled data comparing surgical and non-surgical approaches. Most existing studies are limited by selection bias, where "better risk" patients are assigned to surgery while those with advanced disease or severe comorbidities receive non-operative drainage.

Conclusion

For most patients with hilar cholangiocarcinoma, treatment is palliative. The Segment III bypass remains the surgical standard when the left lobe is not atrophic or heavily involved by tumor. While surgery offers superior long-term patency compared to stents, it carries higher initial risks. Future clinical trials are required to establish optimal protocols for patient subgroups, with a necessary focus on including quality-of-life assessments as a primary metric.